BCD-41812-16192
3 vaccinations
5 coded responses
23 check-ins
5 free-text entries
2 call cases
- Sex
- —
- Age at first dose
- 66+
- ZIP prefix
- 902 / CA
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Registered in v-safe
-
2021-01-28
Dose 1 — Moderna
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
-
2021-03-04
Dose 2 — Moderna
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
-
2021-06-03
Survey response — 3 months, dose 2MedDRA: Contusion, Rash — Feeling: Good · Be unable to do your normal daily activitiesFree text: 6 weeks of post vaccine rash and bruising both arms and lesser so on legs and lower backMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-09
Survey response — 6 months, dose 2MedDRA: Aneurysm, Vasodilatation — Feeling: FairFree text: Severely bulging veins/arteries post vaccineMedDRA releases: 2024-11 · check-in free text available
-
2021-12-14
Dose 3 — Moderna
-
2022-03-04
Survey response — 12 months, dose 2MedDRA: Hair disorder, Skin disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Severe skin/hair issuesMedDRA releases: 2024-11 · check-in free text available
-
2022-06-14
Survey response — 6 months, dose 3MedDRA: Alopecia, Nausea, Rash, Vertigo — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Extreme body hair loss, skin rash, Vertigo and nauseaMedDRA releases: 2024-11 · check-in free text available
-
2022-06-14
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-06-15
- 2022-06-17
-
2022-06-17
Callback requested formorning
-
2022-12-14
Survey response — 12 months, dose 3MedDRA: Alopecia, Office visit, Skin disorder — Feeling: Poor · Get care from a doctor or other healthcare professionalFree text: Symptoms: Continued skin issues and dramatic hair loss overall body and heavily in scalp area. I have reported this issue to you repeatedly since initial vaccination and have received no response or followup regarding these issues so I will no longer respond · Healthcare visit (other): MDMedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-12-15
Call successfulParticipant prefers to complete VAERS report online
-
2022-12-15
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Moderna | |
| 2 | 2021-03-04 | Moderna | |
| 3 | 2021-12-14 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 8 — 3 months, dose 2
Symptoms: 6 weeks of post vaccine rash and bruising both arms and lesser so on legs and lower back
Release 9 — 6 months, dose 2
Symptoms: Severely bulging veins/arteries post vaccine
Release 11 — 12 months, dose 2
Symptoms: Severe skin/hair issues
Release 12 — 6 months, dose 3
Symptoms: Extreme body hair loss, skin rash, Vertigo and nausea
Release 12 — 12 months, dose 3
Symptoms: Continued skin issues and dramatic hair loss overall body and heavily in scalp area. I have reported this issue to you repeatedly since initial vaccination and have received no response or followup regarding these issues so I will no longer respond cut off by CDC
Healthcare visit (other): MD
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Alopecia | · | · | ✓ |
| SD | Aneurysm | · | · | ✓ |
| SD | Contusion | ✓ | ✓ | ✓ |
| SD | Hair disorder | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Skin disorder | · | · | ✓ |
| SD | Vasodilatation | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release